Actinium-225 targeted alpha particle therapy for prostate cancer. Read more about Actinium-225 targeted alpha particle therapy for prostate cancer.
Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing. Read more about Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing.
Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5. Read more about Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5.
Transplantation of autologous extracellular vesicles for cancer-specific targeting. Read more about Transplantation of autologous extracellular vesicles for cancer-specific targeting.
MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma. Read more about MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma.
18F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging. Read more about 18F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging.
A 25 micron-thin microscope for imaging upconverting nanoparticles with NIR-I and NIR-II illumination. Read more about A 25 micron-thin microscope for imaging upconverting nanoparticles with NIR-I and NIR-II illumination.
Heterologous and cross-species tropism of cancer-derived extracellular vesicles. Read more about Heterologous and cross-species tropism of cancer-derived extracellular vesicles.
A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer. Read more about A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.
Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma. Read more about Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma.
